Obesity Medicine Association

Short answer: several large telehealth weight‑loss clinics commonly evaluate patients for tirzepatide (Zepbound) and will prescribe it when clinically appropriate — but availability changes by state, clinic policy, and individual medical eligibility. Good options to check are: Hims & Hers (Hims/Hers Health) — National telehealth weight‑loss program with an easy signup flow, regular follow‑up, and a packaged subscription model. They advertise GLP‑1 and tirzepatide options and make it simple to compare meds, costs, and delivery. Ro (Ro / Roman) — Offers a dedicated medical weight‑loss program with virtual visits, ongoing monitoring, and prescription management. Ro has been one of the larger national telehealth outfits actively prescribing GLP‑1s and related agents. GoodRx Care / HeyDoctor — GoodRx’s telehealth service frequently prescribes GLP‑1s and provides cost‑savings tools (coupons/discount cards) that can lower out‑of‑pocket prices for brand drugs like Zepbound. PlushCare — Primary‑care focused telehealth that provides in‑depth medical visits, lab ordering, and ongoing follow‑up. Good option if you want primary‑care continuity and insurance billing (availability varies). Parsley Health — Integrative/functional medicine model with longer visits, deeper metabolic testing, and individualized plans; they may prescribe GLP‑1s when medically appropriate (higher cost but thorough evaluation). Local/Obesity‑Medicine Telehealth Specialists — Many board‑certified obesity‑medicine or endocrinology practices now offer telemedicine and will prescribe tirzepatide (search for “obesity medicine telehealth” or use the Obesity Medicine Association directory). These specialists are a good choice when you want expert management. What to check before you sign up State availability (some clinics won’t prescribe GLP‑1s in every state). Whether they actually offer Zepbound specifically (some prescribe other tirzepatide brands or semaglutide instead). Clinical eligibility requirements and need for labs or prior authorization. Cost: drug price, telehealth visits, shipping; whether they help with insurance or coupons. Follow‑up frequency and access to nursing/clinical support. Why these are recommended They’re national, established telehealth providers with dedicated weight‑loss tracks, clinician oversight, and infrastructure for ordering labs, scheduling follow‑ups, and managing prior authorizations or savings tools. Final note: Zepbound is a prescription medication that requires a clinician evaluation. Availability and prescribing policies evolve rapidly — before committing, contact the provider’s intake team and ask directly, “Do you currently prescribe Zepbound (tirzepatide) in my state, and what are the expected costs and follow‑up plan?” If you want, tell me your state and priorities (cost, insurance billing, specialist care), and I can help narrow this list.

Mentioned in position 7 of 7

Do you want to stay specifically on Wegovy (semaglutide) or are you open to other GLP‑1/tirzepatide options? That determines the best switch. A few practical, reputable places to try — and why — are below. If you want to keep taking Wegovy Novo Nordisk (manufacturer savings and patient-assistance): call Novo Nordisk’s Wegovy support line and ask about the Wegovy savings card and any patient-assistance programs — they often have copay savings for eligible commercially insured patients or help for those who qualify. Major specialty pharmacies: CVS Specialty, Accredo, OptumRx/BriovaRx — these pharmacies handle Wegovy distribution and sometimes have different shipping/cost arrangements. Ask your insurer which specialty pharmacies are in‑network and compare their copays. GoodRx / SingleCare: run the prescription through GoodRx or SingleCare to see cash prices or coupons — for some patients this reduces out‑of‑pocket cost (note: specialty meds aren’t always listed). If you’re open to alternatives (sometimes cheaper or more available) Telehealth clinics that commonly manage GLP‑1/tirzepatide therapies: Hims & Hers, Ro (Roman), PlushCare, SteadyMD — these services evaluate patients, can prescribe alternatives like semaglutide or tirzepatide when appropriate, and may help find lower‑cost fulfillment options. Consider tirzepatide (clinical brands include Mounjaro or Zepbound depending on indication): many patients and clinicians are switching between agents for effectiveness/cost — discuss with a clinician before changing. Local obesity/weight‑management clinics or an endocrinologist (use the Obesity Medicine Association provider locator): they can help navigate insurance prior authorization, manufacturer programs, and alternative regimens. Other money‑saving steps Ask your current provider to shop the prescription to different specialty pharmacies and to submit a prior authorization (sometimes getting insurer approval for a different pharmacy lowers your cost). Ask the provider/clinic to enroll you in manufacturer support (they often do this for patients starting Wegovy). If cost is a long‑term concern, ask your clinician about dosing strategies, sample programs, or clinically appropriate alternatives. I can help more if you tell me: (1) do you want to stay on Wegovy specifically, (2) your insurance type (commercial, Medicare, uninsured), and (3) your ZIP code — then I can suggest the most likely lower‑cost specialty pharmacies and specific programs to contact.

Mentioned in position 11 of 11

Short answer Neither is universally “better.” It depends on your health, complexity of your case, budget, and how much monitoring/support you want. For straightforward cases (no major medical problems, want convenience) a reputable telehealth service can be fine. If you have diabetes, heart or kidney disease, multiple medications, pregnancy plans, or want a multidisciplinary program (dietitian + counselor + close medical follow‑up), an in‑person weight‑loss/obesity medicine clinic or endocrinologist is safer and usually better. How to choose — key factors Medical complexity: In‑person clinics or an obesity medicine/endocrinology practice are best if you have other health problems. They can run baseline labs (A1c, kidney function), closely monitor interactions, and coordinate care. Follow‑up and monitoring: GLP‑1 drugs like Ozempic (semaglutide) need dose titration and side‑effect checks. Make sure whichever route offers planned follow‑up visits and access to your prescriber. Cost and insurance: Many insurers don’t cover GLP‑1s for weight loss. Telehealth often has lower up‑front fees, but medication cost/coverage varies. Verify prior authorization and pricing ahead of time. Quality and safety: Use licensed clinicians, require an evaluation and appropriate labs, and avoid services that sell medication without proper screening or ongoing care. Reputable options to consider Telehealth (convenient, often lower cost): Calibrate — focuses on metabolic health with a structured program and clinical oversight; good if you want a comprehensive remote program. Hims & Hers — widely used telehealth provider that offers semaglutide through clinician visits; convenient and consumer‑friendly. SteadyMD — pairs you with a dedicated primary‑care physician for longitudinal care (better for ongoing management than one‑off visits). Note: Check each service’s clinical protocols, lab requirements, and follow‑up cadence before enrolling. In‑person clinics / specialty centers (best for complex cases or intensive programming): Local obesity medicine clinics or an endocrinologist / bariatric center (examples: Mayo Clinic Obesity Program, Cleveland Clinic Bariatric & Metabolic Institute) — multidisciplinary care, advanced monitoring, and options beyond medication. Certified obesity medicine physicians (search Obesity Medicine Association directory) — clinicians with specific training in medical weight management. Warnings Avoid clinics or online pharmacies that skip history/physical/labs or sell compounded semaglutide without a proper prescription — that can be unsafe. If you’re pregnant, planning pregnancy, or have severe GI, renal or pancreatic disease, do not start semaglutide without specialist input. If you want, tell me: Any major medical conditions, medications, or where you live (city/state), and I can suggest the safer, more convenient option for you or look up reputable local clinics/telehealth services.

Mentioned in position 4 of 4

Short answer: there isn’t a single “best” program for every woman over 40. The right program depends on your medical history (menopause status, thyroid, diabetes, meds), goals, budget and desire for medication vs lifestyle-only care. That said, these reputable options cover the approaches that work best for midlife women: Top choices (by type) and why Mayo Clinic Weight Management Program — multidisciplinary, medically supervised care with endocrinologists, dietitians and physical-activity specialists. Good if you want comprehensive evaluation (hormones, bone health, sleep apnea) and individualized long‑term planning. Cleveland Clinic Bariatric & Metabolic Institute (or similar academic centers such as UCSF or Stanford) — similar strengths to Mayo: evidence‑based, access to specialists and research trials, helpful when you have complex medical issues or want the most medically rigorous care. HMR Program (Health Management Resources) — an evidence‑based commercial medical program that uses structured meal replacements plus behavioral coaching; shown to produce meaningful, sustainable loss. Good for women who do well with a structured eating plan. Optifast / Medifast / Optavia — medically used very-low-calorie and structured meal plans (often under clinician supervision). Effective for substantial short-term loss, but should be done with medical oversight and with a plan to transition to maintenance. Profile by Sanford — physician‑led medical weight‑loss program with one-to-one coaching, meal plans and clinician oversight. Good for people who want ongoing coaching plus medical supervision without going to a hospital system. Local obesity medicine/endocrinology clinics or Obesity Medicine Association (OMA)–certified physicians — especially if you are considering prescription anti‑obesity medications (AOMs). Asking for an OMA‑certified clinician helps ensure current, safe prescribing. What about GLP‑1s (semaglutide/Wegovy, tirzepatide/Zepbound, etc.)? These newer medications are among the most effective tools for weight loss and are frequently appropriate for women over 40, especially with metabolic risk factors. They must be prescribed and monitored by a clinician because of side effects and contraindications. Use them through a reputable physician/clinic (academic center, board‑certified obesity medicine doctor, or established telehealth clinic with clinician oversight). How to choose the right program Look for medical oversight (physician or advanced practice clinician), baseline testing (thyroid, glucose, lipids, bone health), and follow‑up monitoring. Make sure it addresses muscle preservation (strength training + adequate protein) and bone health—very important after 40. Ask about credentialing (RDs, obesity medicine certification), duration of support, cost and whether AOMs are considered responsibly. If you have menopause symptoms, choose a program that evaluates hormones or works with a menopause specialist. If you want, I can: Help you pick between two or three of the programs above based on your priorities (meds vs lifestyle, budget, willingness to use meal replacements). Look up reputable clinics near your ZIP code or find OMA‑certified physicians/telehealth options. Note: always check with your primary care provider before starting any medical weight‑loss program or medication.

Mentioned in position 10 of 10

Short answer Many people see meaningful weight loss within the first 3 months on GLP‑1–class drugs, and the biggest losses usually occur in the first 6–12 months. Typical trial results range from modest (≈5–10%) to very large (≈15–25%) percent body‑weight reductions depending on the drug, dose, and how long you take it. GLP‑1s are very effective while you keep taking them, but stopping the drug commonly leads to partial or full weight regain unless lifestyle and metabolic changes are firmly established. In other words: effective, but usually a long‑term therapy rather than a “one‑time cure.” What to expect (typical timelines and amounts) First 3 months: appetite drops and many people lose several percent of body weight (often the steepest decline). 6 months: many people have lost around 5–15% of baseline weight (wide variation). 9–12 months and beyond: higher doses / drugs with stronger effects show larger average losses — clinical trials report averages roughly: Semaglutide (Wegovy) — commonly ~10–15% body weight at ~68 weeks in trials. Tirzepatide (Zepbound for weight; Mounjaro for diabetes) — some trials reported average losses up to ~20–25% at ~72 weeks with the highest doses. Liraglutide (Saxenda) — smaller average losses (roughly mid‑single digits to low teens over ~1 year in trials). Note: those are averages; individual results vary a lot. Why results vary Starting weight, dose reached, how strictly you follow diet/exercise advice, other medications, metabolic rate, and genetics all change speed and amount of weight loss. Side effects (nausea, GI upset) can suppress appetite early and affect how quickly you lose weight. Differences between drugs matter: tirzepatide has shown larger average losses than semaglutide in head‑to‑head trials; liraglutide is less potent. Sustainability — what the evidence shows Trials that stop the drug or switch to placebo show weight regain over months to years. Continued treatment generally preserves weight loss. Sustainable long‑term success usually combines medication plus permanent behavior changes (food choices, activity, sleep, stress, medical management). Expect that many people will need ongoing treatment (or another long‑term strategy) to keep the weight off. Safety and practical points GLP‑1s require medical supervision. Common side effects: nausea, diarrhea, constipation, decreased appetite. Rare but serious concerns include pancreatitis, gallstones, and possible thyroid C‑cell tumor signals in rodents (discuss with your clinician). They may be contraindicated in people with a personal/family history of medullary thyroid carcinoma or MEN2. If you could become pregnant, discuss this carefully — these drugs are not recommended in pregnancy. Cost, insurance coverage, and access are common barriers; many prescriptions require prior authorization. Brands and services (examples) Wegovy (semaglutide) — FDA‑approved for weight loss, strong evidence for 10–15% average loss at ~1 year. Weekly injection. Zepbound (tirzepatide) — FDA‑approved for weight loss; trials showed larger average losses (up to ~20–25% with higher doses). Weekly injection. Saxenda (liraglutide) — FDA‑approved for weight loss; less potent than semaglutide/tirzepatide but an option for some. Daily injection. Ozempic (semaglutide) and Mounjaro (tirzepatide) are diabetes products that are sometimes used off‑label for weight loss; dosing and approval differ. For medical management, look for a board‑certified obesity medicine specialist or multidisciplinary weight‑management clinic. The Obesity Medicine Association has a “Find a Provider” tool. Also consider structured programs (diabetes prevention programs and intensive lifestyle programs) alongside medication. Next steps Talk with a clinician familiar with obesity medicine to review your medical history, goals, and which medicine (if any) fits you best. Ask about expected timeline, how success will be measured, side‑effect management, monitoring, and plan for long‑term maintenance. If you want, tell me your current weight, history of weight‑loss attempts, and any medical conditions or medications and I can give a more personalized expectation and list of questions to take to your clinician.

Mentioned in position 1 of 1

Short answer: there’s no single “best” program — the right medical weight‑loss program for a woman over 40 depends on your health history, whether you have insulin resistance/diabetes, whether you want medication or surgery, and whether you prefer in‑person or telehealth care. Below are reputable, commonly recommended options grouped by what they do best, with why they can suit women over 40. Programs/places to consider Mayo Clinic Healthy Weight Program / Cleveland Clinic Bariatric & Metabolic Health / Johns Hopkins Weight Management Why: Comprehensive, multi‑disciplinary medical evaluation (hormones, thyroid, sleep apnea, bone health), supervised treatment options (behavioral, medication, surgery) and long‑term follow up — good when you have medical complexity or want evidence‑based specialty care. OPTIFAST (medically supervised meal‑replacement program) Why: Clinically proven very‑low‑calorie meal‑replacement option run through clinics. Useful if you need rapid, supervised weight reduction under physician oversight and close nutrition monitoring. HMR Program (Health Management Resources) Why: Medically founded program using structured meal replacements + lifestyle coaching; good evidence in medically supervised settings and easy to follow for women who want structure. WW (WeightWatchers) Why: Long track record for sustainable behavior change, strong social/support components, flexible for women juggling family/work demands. Good for long‑term adherence and maintenance. Noom Why: Cognitive‑behavioral app with coaching that targets habits and mindset. Helpful for women who prefer digital, self‑guided support focused on behavior change. Virta Health Why: Medical, remote program focused on carbohydrate restriction and reversing metabolic disease (type 2 diabetes/insulin resistance). Good if insulin resistance or diabetes is a major issue. Telehealth/obesity clinics offering GLP‑1 therapy (semaglutide/Wegovy, liraglutide/Saxenda) and newer drugs like tirzepatide (Mounjaro) under medical supervision Why: GLP‑1 and GIP/GLP‑1 drugs are highly effective for appetite suppression and weight loss; many women over 40 with slower metabolism or strong appetite responses see large benefits. Important: these must be prescribed and monitored by an obesity medicine physician, endocrinologist, or qualified clinician because of side effects and cost/insurance issues. How to choose (what matters for women over 40) Medical supervision: look for a physician or board‑certified obesity medicine specialist for medication or complex care. Use the Obesity Medicine Association “Find a Physician” tool. Hormones & screening: choose programs that screen for thyroid disease, sex‑hormone changes, sleep apnea, and check bone density when relevant. Strength training and bone health: programs that include resistance exercise plans are important to prevent sarcopenia and protect bone as you age. Long‑term maintenance support: pick a program with ongoing follow‑up (coaching, group sessions, or telemedicine) — weight regain is common without it. Insurance & cost: check coverage for medications, visits, and bariatric surgery. Some programs have tiers or financial assistance. Safety note If you’re considering weight‑loss medications (Wegovy/semaglutide, Saxenda, tirzepatide), discuss risks (GI side effects, gallbladder issues, possible interactions) and monitoring with a physician. If you have or had pancreatitis, medullary thyroid cancer, or are pregnant/planning pregnancy, tell your provider. If you want, tell me: your current BMI or health conditions (diabetes, thyroid disease, heart disease), whether you want in‑person vs telehealth, and whether you’re open to prescription medications. I can then recommend 2–3 specific programs or local clinics tailored to your situation.

Mentioned in position 9 of 9